Rchr
J-GLOBAL ID:202301015274822827   Update date: Sep. 29, 2025

UEDA KEIJIRO

植田 圭二郎 | UEDA KEIJIRO
Affiliation and department:
Research theme for competitive and other funds  (2):
  • 2025 - 2028 Precision Medicine for Pancreatic Cancer Using Patient-Derived Organoids Based on Subtype Classification
  • 2023 - 2026 膵癌オルガノイドを用いた形態学的サブタイプ分類の試みと臨床応用
Papers (53):
  • Naoki Ikenaga, Kohei Nakata, Toshiya Abe, Yusuke Watanabe, Noboru Ideno, Masatoshi Murakami, Keijiro Ueda, Nao Fujimori, Nobuhiro Fujita, Kousei Ishigami, et al. Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. Surgery. 2025. 178. 108958-108958
  • Nao Fujimori, Nobuhiro Fujita, Masatoshi Murakami, Akihisa Ohno, Kazuhide Matsumoto, Katsuhito Teramatsu, Keijiro Ueda, Noriaki Wada, Seiichiro Takao, Daisuke Okamoto, et al. Usefulness of Semiautomated 3D Volumetric Assessment of Liver Tumor Burden for Patients With Unresectable Pancreatic Neuroendocrine Tumor: A Pilot Study. Pancreas. 2025. 54. 2. e122-e129
  • Yasuhiro Komori, Akihisa Ohno, Nao Fujimori, Kazuhide Matsumoto, Keijiro Ueda, Kazuki Takeishi, Tomoharu Yoshizumi, Yoshihiro Ogawa. Follow-up computed tomography can prevent stent migration after endoscopic ultrasound-guided hepaticogastrostomy. International Journal of Gastrointestinal Intervention. 2025
  • 村上 正俊, 藤森 尚, 宮ヶ原 典, 赤木 健哉, 川口 夢佳, 末永 顕彦, 上田 孝洋, 梯 祥太郎, 大野 彰久, 松本 一秀, et al. 【希少領域,治療困難例における膵・胆道癌の薬物療法】治療困難な膵・胆道癌の薬物療法 閉塞性・拘束性肺障害合併胆道癌・膵癌の薬物療法および薬剤性肺障害について. 胆と膵. 2024. 45. 11. 1669-1675
  • Akihisa Ohno, Nao Fujimori, Toyoma Kaku, Yuzo Shimokawa, Tsukasa Miyagahara, Yuta Suehiro, Anthony Gerodias, Shotaro Kakehashi, Kazuhide Matsumoto, Masatoshi Murakami, et al. Feasibility of Endoscopic Ultrasound-Guided Hepaticogastrostomy for Malignant Hilar Biliary Obstruction. Digestive diseases and sciences. 2024
more...
MISC (3):
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page